Dopamine in drug abuse and addiction: results from imaging studies and treatment implications

被引:0
|
作者
N D Volkow
J S Fowler
G-J Wang
J M Swanson
机构
[1] National Institute on Drug Abuse,Medical Department
[2] National Institute on Alcohol Abuse and Alcoholism,Chemistry Department
[3] Brookhaven National Laboratory,Department of Psychiatry
[4] Brookhaven National Laboratory,Department of Pediatrics
[5] State University of New York at Stony Brook,undefined
[6] University of California,undefined
来源
Molecular Psychiatry | 2004年 / 9卷
关键词
PET; orbitofrontal cortex; cingulate gyrus; striatum; dopamine transporters; dopamine D2 receptors; reward; motivation; predisposition; salience; pharmacokinetics;
D O I
暂无
中图分类号
学科分类号
摘要
The involvement of dopamine in drug reinforcement is well recognized but its role in drug addiction is much less clear. Imaging studies have shown that the reinforcing effects of drugs of abuse in humans are contingent upon large and fast increases in dopamine that mimic but exceed in the intensity and duration those induced by dopamine cell firing to environmental events. In addition, imaging studies have also documented a role of dopamine in motivation, which appears to be encoded both by fast as well as smooth DA increases. Since dopamine cells fire in response to salient stimuli, the supraphysiological activation by drugs is likely to be experienced as highly salient (driving attention, arousal conditioned learning and motivation) and may also reset the thresholds required for environmental events to activate dopamine cells. Indeed, imaging studies have shown that in drug-addicted subjects, dopamine function is markedly disrupted (decreases in dopamine release and in dopamine D2 receptors in striatum) and this is associated with reduced activity of the orbitofrontal cortex (neuroanatomical region involved with salience attribution and motivation and implicated in compulsive behaviors) and the cingulate gyrus (neuroanatomical region involved with inhibitory control and attention and implicated in impulsivity). However, when addicted subjects are exposed to drug-related stimuli, these hypoactive regions become hyperactive in proportion to the expressed desire for the drug. We postulate that decreased dopamine function in addicted subjects results in decreased sensitivity to nondrug-related stimuli (including natural reinforcers) and disrupts frontal inhibition, both of which contribute to compulsive drug intake and impaired inhibitory control. These findings suggest new strategies for pharmacological and behavioral treatments, which focus on enhancing DA function and restoring brain circuits disrupted by chronic drug use to help motivate the addicted subject in activities that provide alternative sources of reinforcement, counteract conditioned responses, enhance their ability to control their drive to take drugs and interfere with their compulsive administration.
引用
收藏
页码:557 / 569
页数:12
相关论文
共 50 条
  • [41] Where and when ketamine alters the dopamine system: translational implications for drug addiction and psychoses
    Calandro, S.
    Avvisati, L.
    Latte, G.
    Patri, A.
    Rossi, R.
    Buonaguro, E. F.
    Sarappa, C.
    Iasevoli, F.
    Aloj, L.
    de Bartolomeis, A.
    [J]. EUROPEAN NEUROPSYCHOPHARMACOLOGY, 2011, 21 : S26 - S27
  • [42] Positron emission tomography imaging studies of dopamine receptors in primate models of addiction
    Nader, Michael A.
    Czoty, Paul W.
    Gould, Robert W.
    Riddick, Natallia V.
    [J]. PHILOSOPHICAL TRANSACTIONS OF THE ROYAL SOCIETY B-BIOLOGICAL SCIENCES, 2008, 363 (1507) : 3223 - 3232
  • [43] MODELS OF ADDICTION AND RECOVERY UTILIZED BY ALCOHOL AND DRUG ABUSE TREATMENT PROGRAMS IN MIAMI
    Pagano, A.
    [J]. ALCOHOLISM-CLINICAL AND EXPERIMENTAL RESEARCH, 2012, 36 : 74A - 74A
  • [44] Dopamine- and serotonin-receptors in schizophrenia: results of imaging-studies and implications for pharmacotherapy in schizophrenia
    S. Kasper
    J. Tauscher
    B. Küfferle
    C. Barnas
    L. Pezawas
    S. Quiner
    [J]. European Archives of Psychiatry and Clinical Neuroscience, 1999, 249 (Suppl 4) : S83 - S89
  • [45] Dopamine- and serotonin-receptors in schizophrenia:: results of imaging-studies and implications for pharmacotherapy in schizophrenia
    Kasper, S
    Tauscher, J
    Küfferle, B
    Barnas, C
    Pezawas, L
    Quiner, S
    [J]. EUROPEAN ARCHIVES OF PSYCHIATRY AND CLINICAL NEUROSCIENCE, 1999, 249 : 83 - 89
  • [46] Addiction and dopamine: sex differences and insights from studies of smoking
    Petersen, Nicole
    London, Edythe D.
    [J]. CURRENT OPINION IN BEHAVIORAL SCIENCES, 2018, 23 : 150 - 159
  • [47] Brain imaging studies of cocaine abuse: Implications for medication development
    London, ED
    Bonson, KR
    Ernst, M
    Grant, S
    [J]. CRITICAL REVIEWS IN NEUROBIOLOGY, 1999, 13 (03): : 227 - 242
  • [48] A Drug Abuse Treatment Guide Available for Home Health Nurses: The National Institute on Drug Abuse's Principles of Drug Addiction Treatment: A Research-Based Guide
    Thobaben, Marshelle
    [J]. HOME HEALTH CARE MANAGEMENT AND PRACTICE, 2010, 22 (05): : 376 - 377
  • [49] CASE STUDIES IN FAMILY TREATMENT OF DRUG-ABUSE
    NOONE, RJ
    REDDIG, RL
    [J]. FAMILY PROCESS, 1976, 15 (03) : 325 - 332
  • [50] Role of dopamine in the therapeutic and reinforcing effects of methylphenidate in humans: results from imaging studies
    Volkow, ND
    Fowler, JS
    Wang, GJ
    Ding, YS
    Gatley, SJ
    [J]. EUROPEAN NEUROPSYCHOPHARMACOLOGY, 2002, 12 (06) : 557 - 566